MLTX seeing an increase of 26% today. A look at what's happening:

MoonLake Immunotherapeutics (MLTX) is trading 26% higher at $6.95 today. While there was no clear and immediate catalyst for the increase in price, the company had recently been upgraded in ratings by several firms.

MoonLake Immunotherapeutics has been trading between a 52-week high of $15.19 and a 52-week low of $4.25. The stock has a market cap of $257 Million.

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, a novel investigational Nanobody® for the treatment of inflammation, to elevate outcomes for patients.